Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03288480 |
| Title | A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Phosplatin Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic Cancer Center | Phoenix | Arizona | 85054 | United States | Details | |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80220 | United States | Details | |
| Mayo Clinic Cancer Center | Jacksonville | Florida | 32224 | United States | Details | |
| Mayo Clinic Cancer Center | Rochester | Minnesota | 55905 | United States | Details | |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| Texas Oncology San Antonio Medical Center | San Antonio | Texas | 78240 | United States | Details |